Miriam Gravellone

ORCID: 0000-0002-7275-2768
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Systemic Sclerosis and Related Diseases
  • Cardiovascular Function and Risk Factors
  • Pulmonary Hypertension Research and Treatments
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Cardiovascular Disease and Adiposity
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Effects of Exercise
  • Lipoproteins and Cardiovascular Health
  • Heart Failure Treatment and Management
  • Cancer, Lipids, and Metabolism
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cardiovascular Syncope and Autonomic Disorders
  • Medical Imaging and Pathology Studies
  • ECG Monitoring and Analysis

University of Palermo
2023

Instituto di Biofisica
2023

National Research Council
2023

CTO Andrea Alesini
2020-2021

Ospedale degli Infermi
2021

Presidio Ospedaliero
2020

Azienda Ospedaliera G.Rummo
2020

Ospedale Garibaldi
2019

Azienda Ospedaliero Universitaria Maggiore della Carita
2016-2018

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
2016-2018

Leonardo De Luca Dario Formigli Jennifer Meessen Massimo Uguccioni Nicola Cosentino and 95 more Claudio Paolillo Andrea Di Lenarda Furio Colivicchi Domenico Gabrielli Michele Massimo Gulizia Marino Scherillo Patrizia Maras Federica Ramani Colomba Falcone Ilaria Passarelli Silvia Mauri Paolo Calabrò Renatomaria Bianchi Gaetano Di Palma F Mascia A Vetrano Adelaide Fusco E Proia Furio Colivicchi Alessandro Aiello Fabrizio Tomai R. Licitra A. Petrolini B. Bosco F Magliari M Callerame T Mazzella G.V. Lettica Gianluca Lo Coco F Incao Lina Marinacci Sandra D’Addario Sara Tartaglione S. Ubaldi Federico Ariel Sànchez Paolo Costa Giuseppe Manca Marcelo Antunes Failla Marino Scherillo Vincenza Procaccini Dario Formigli Michele Senni E M Luminita Paolo Bonomo C Mossa Stefano Corda Angela Rita Colavita G Trevisonno Giampiero Vizzari Nicola Cosentino C Formaro Claudio Paolillo I L Nalin Francesco Mario De Rosa F Fontana G.F. Fuscaldo Enrico Passamonti E. Bertella Elva Calvaruso Elisabetta Varani F Tani Giordano Cicchitelli Domenico Gabrielli P Paoloni Alessandro Marziali Gianluca Campo Matteo Tebaldi Simone Biscaglia Matteo Di Biase Natale Daniele Brunetti Andrea Gallotta Luisa Mattei R. Marini F. Balsemin Maurizio DʼUrbano Rita Naio Paolo Vicinelli Giuseppe Arena Maria Cristina Ritter Mazzini N Gigli Bruna Miserrafiti Angela Monopoli Andrea Mortara Pietro Delfino Margherita Chioffi Paolo Marino Miriam Gravellone Lucas Regatieri Barbieri Antonietta Ledda Giovanna Geraci Maria Gabriella Carmina A Raisaro C Di Giacomo Alberto Somaschini Maria Luisa Fasano

Abstract Aims Recently, the cardiovascular outcomes for people using anticoagulation strategies (COMPASS) trial demonstrated that dual therapy reduced compared with aspirin alone in patients stable atherosclerotic disease. Methods and results We sought to assess proportion of eligible COMPASS compare epidemiology outcome these those without inclusion or any exclusion criteria a contemporary, nationwide cohort coronary artery Among 4068 detailed information allowing evaluation eligibility,...

10.1093/ehjqcco/qcaa054 article EN European Heart Journal - Quality of Care and Clinical Outcomes 2020-06-11

SARS-CoV-2 infection has caused a global pandemic. Many of the medications identified to treat COVID-19 could be connected with QTc prolongation and its consequences.Non-ICU hospitalized patients three centres involved in study from 19th March 1st May were included this retrospective multicentre study. Relevant clinical data digitally collected. The primary outcome was incidence ≥ 500 ms, main secondary outcomes Tisdale score ability predict ventricular arrhythmias sudden deaths.196...

10.1016/j.ijcha.2020.100637 article EN cc-by-nc-nd IJC Heart & Vasculature 2020-09-11

Aims Increased right atrial size is related to adverse prognosis in pulmonary hypertension. The potential incremental value of function assessment still unclear. We tested the relationship between two-dimensional speckle-tracking echocardiography impairment and hemodynamic, functional clinical deterioration patients with Methods prospectively evaluated 36 (27 female, 9 male; mean age 68 ± 13 years) suspected hypertension undergoing heart catheterization 16 matched controls. All underwent...

10.2459/jcm.0000000000000525 article EN Journal of Cardiovascular Medicine 2017-06-27

Dell’Era, Gabriele; Porcellini, Stefano; Boggio, Enrico; Prenna, Eleonora; Gravellone, Miriam; Varalda, Marco; Erbetta, Riccardo; Lio, Veronica; Occhetta, Eraldo; Marino, Paolo Author Information

10.2459/jcm.0000000000000689 article EN Journal of Cardiovascular Medicine 2018-07-07

Cardiac contractility modulation (CCM) is a treatment option for patients suffering symptomatic chronic heart failure (CHF) with reduced left ventricular ejection fraction (LVEF) who are not eligible cardiac resynchronization. Data on mid-term follow-up limited to small observational studies. The aim of this study was assess the impact CCM quality life, symptoms, exercise tolerance and function in CHF moderate-to-severe systolic dysfunction.Patients LVEF <45% NYHA class >II despite optimal...

10.23736/s2724-5683.20.05219-6 article EN Minerva Cardiology and Angiology 2021-03-01

Up to one-third of patients undergoing cardiac resynchronization therapy (CRT) are nonresponders. Multipoint bicathodic and cathodic-anodal left ventricle (LV) stimulations could overcome this clinical challenge, but their effectiveness remains controversial. Here we evaluate the performance such through both in vivo silico experiments, latter based on computer electromechanical modeling. Seven patients, all candidates for CRT, received a quadripolar LV lead. Four were tested: right...

10.1016/j.compbiomed.2021.104661 article EN cc-by-nc-nd Computers in Biology and Medicine 2021-07-22

Introduction: Systemic sclerosis (SSc) is at risk of developing pulmonary vasculopathy (PV) leading to arterial hypertension (PAH), right heart failure and death. Early detection this life-limiting complication may allow timely therapy improve patients’ survival. Nevertheless, standard non-invasive screening tests are not fully adequate identify milder degrees vascular disease catheterization reserved hemodynamic confirmation. An integrating strategy including reliable specific...

10.1161/circ.134.suppl_1.13061 article EN Circulation 2016-11-11

Abstract Background Cardiac re-synchronization therapy (CRT) reduces mortality and hospitalization in patients with heart failure, reduced left ventricular ejection fraction (LVEF) bundle branch block (LBBB). However, there is no conclusive evidence on baseline parameters able to discriminate responder vs non-responder patients. Purpose In this study, we tested whether echocardiographic describing LV dyssynchrony efficiency may predict an acute recovery after CRT lead position can modify...

10.1093/ehjci/ehaa946.0812 article EN European Heart Journal 2020-11-01

Abstract Background Cardiac resynchronization therapy (CRT) is an established treatment for heart failure with reduced ejection fraction (HFrEF). However, one third of patients are “non responders”. Cathodic-anodal (CA) left ventricle (LV) capture a multisite pacing occurring during CRT using both bipolar and quadripolar LV lead. It allows depolarization to arise simultaneously from the cathode anode bipole located on epicardium, activating larger volume myocardium than cathodal alone, thus...

10.1093/ehjci/ehaa946.0799 article EN European Heart Journal 2020-11-01
Coming Soon ...